Skip to main content
Midas Edge

Verastem, Inc.

For the period ended Dec 31, 2024. Filed Mar 20, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 20, 2025

VSTM$8.73+0.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Statements of Stockholders’ (Deficit) Equity

CONSOLIDATED STATEMENTS OF****CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ (DEFICIT) EQUITY

(in thousands, except share data)

​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · Accumulated · ​ · ​ · ​ · ​ · ​
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · other · ​ · ​ · ​ · ​
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · Additional · ​ · comprehensive · ​ · ​ · ​ · Total
​ · ​ · Series B Convertible Preferred Stock · ​ · ​ · Series A Convertible Preferred Stock · ​ · Common stock · ​ · paid-in · ​ · (loss) · ​ · Accumulated · ​ · stockholders'
​ · Shares · Amount · Shares · Amount · Shares · Amount · capital · income · deficit · equity
Balance at December 31, 2021​—​$—​​—​$—​15,440,830​$2​$751,234​$34​$(663,711)​$87,559​
Net loss​—​​—​​—​​—​—​—​​—​​—​​(73,812)​(73,812)​
Unrealized loss on available-for-sale marketable securities​—​​—​​—​​—​—​​—​​—​​(34)​​—​(34)​
Issuance of Series A Convertible Preferred Stock in exchange for common stock​—​​—​​1,000,000​​—​(833,333)​​—​​—​​—​​—​—​
Issuance of common stock under Employee Stock Purchase Plan​—​​—​​—​​—​10,194​​—​​164​​—​​—​​164​
Issuance of common stock resulting from vesting of restricted stock units​—​​—​​—​​—​121,441​​—​​—​​—​​—​​—​
Issuance of common stock resulting from exercise of stock options​—​​—​​—​​—​8,181​​—​​118​​—​​—​118​
Issuance of common stock resulting from at-the-market transactions, net​—​​—​​—​​—​1,964,448​​—​​27,349​​—​​—​27,349​
Stock-based compensation expense​—​​—​​—​​—​—​​—​​6,047​​—​​—​​6,047​
Balance at December 31, 2022​—​$—​​1,000,000​$—​16,711,761​$2​$784,912​$—​$(737,523)​$47,391​
Net loss​—​​—​​—​​—​—​​—​​—​​—​​(87,367)​(87,367)​
Unrealized gain on available-for-sale marketable securities​—​​—​​—​​—​—​​—​​—​​13​​—​13​
Issuance of Series B Convertible Preferred Stock, net of issuance costs of $1,901 and preferred stock tranche liability of $6,940​1,200,000​​21,159​​—​​—​—​​—​​—​​—​​—​​—​
Issuance of common stock, and pre-funded warrants, net of issuance cost of $6,351​—​​—​​—​​—​8,489,409​​1​​91,419​​—​​—​91,420​
Issuance of common stock under Employee Stock Purchase Plan​—​​—​​—​​—​14,270​​—​​57​​—​​—​​57​
Issuance of common stock resulting from vesting of restricted stock units​—​​—​​—​​—​65,710​​—​​—​​—​​—​—​
Stock-based compensation expense​—​​—​​—​​—​​​​​​​5,860​​—​​—​5,860​
Balance at December 31, 2023​1,200,000​$21,159​​1,000,000​$—​25,281,150​$3​$882,248​$13​$(824,890)​$57,374​
Net loss​—​​—​​—​​—​—​​—​​—​​—​​(130,637)​(130,637)​
Unrealized loss on available-for-sale marketable securities​—​​—​​—​​—​—​​—​​—​​(13)​​—​(13)​
Issuance of common stock and pre-funded warrants, net of issuance costs of $1,179​—​​—​​—​​—​13,333,334​​1​​14,220​​—​​—​​14,221​
Conversion of Series B Convertible Preferred Stock to common stock​(1,200,000)​​(21,159)​​—​​—​4,236,568​​—​​21,159​​—​​—​​21,159​
Issuance of common stock upon exercise of pre-funded warrants​—​​—​​—​​—​1,538,201​​—​​—​​—​​—​—​
Issuance of common stock upon exercise of warrants​—​​—​​—​​—​250,000​​—​​1,420​​—​​—​​1,420​
Issuance of common stock resulting from exercise of stock options​—​​—​​—​​—​21,978​​—​​172​​—​​—​​172​
Issuance of common stock under Employee Stock Purchase Plan​—​​—​​—​​—​15,231​​—​​69​​—​​—​​69​
Issuance of common stock resulting from vesting of restricted stock units​—​​—​​—​​—​107,888​​—​​—​​—​​—​—​
Stock-based compensation expense​—​​—​​—​​—​—​​—​​7,342​​—​​—​7,342​
Balance at December 31, 2024​—​$—​​1,000,000​$—​44,784,350​$4​$926,630​$—​$(955,527)​$(28,893)​
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.